Similar Papers

Paper Title
Journal
Date
Author
DNA methylation profiling in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
Angelika Martina Starzer ... Stefan Traint
Journal of Clinical Oncology | VOL. 38
Angelika Martina Starzer, et. al.Angelika Martina Starzer ... Stefan Traint
20 May 2020
Abstract 1558: TP53 codon 72 polymorphism association with prognosis in Puerto Rican head and neck squamous cell carcinoma patients
Bianca L Rivera ... Roger Vázquez
Cancer Research | VOL. 74
Bianca L Rivera, et. al.Bianca L Rivera ... Roger Vázquez
30 Sep 2014
CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study
Chunhong Li ... Jiahua Hu
Hereditas | VOL. 159
Chunhong Li, et. al.Chunhong Li ... Jiahua Hu
27 Sep 2022
Immune Cell Infiltrates and Neutrophil-to-Lymphocyte Ratio in Relation to Response to Chemotherapy and Prognosis in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas.
Mario Sánchez-Canteli ... Aurora Astudillo
Cancers | VOL. 13
Mario Sánchez-Canteli, et. al.Mario Sánchez-Canteli ... Aurora Astudillo
25 Apr 2021
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry
Alessio Cortellini ... Biagio Ricciuti
Journal for ImmunoTherapy of Cancer | VOL. 13
Alessio Cortellini, et. al.Alessio Cortellini ... Biagio Ricciuti
04 Feb 2025
Modulating lipid metabolism improves tumor immunotherapy
Yu Ping ... Yi Zhang
Journal for ImmunoTherapy of Cancer | VOL. 13
Yu Ping, et. al.Yu Ping ... Yi Zhang
04 Feb 2025
Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis
Cameron Wood ... Neal Ready
Journal for ImmunoTherapy of Cancer | VOL. 13
Cameron Wood, et. al.Cameron Wood ... Neal Ready
04 Feb 2025
Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma
Thomas Eigentler ... Ulrike Gnad-Vogt
Journal for ImmunoTherapy of Cancer | VOL. 13
Thomas Eigentler, et. al.Thomas Eigentler ... Ulrike Gnad-Vogt
04 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.